BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7822200)

  • 1. [Value of nucleolus organizer regions (AgNORs) in dermatologic oncology].
    Pfau A; Eckert F; Schröpfer T; Rüschoff J
    Hautarzt; 1994 Nov; 45(11):762-8. PubMed ID: 7822200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AgNOR (nucleolar organizer regions) staining in malignant melanoma.
    Nagatani T; Iemoto G; Miyakawa K; Ichiyama S; Takahashi Y; Uchiyama M; Nakajima H
    J Dermatol; 1991 Dec; 18(12):731-5. PubMed ID: 1806604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinguishing benign and malignant melanocytic lesions with the AgNOR method.
    Friedman RJ; Grin CM; Heilman E; Weiser J; Gottlieb GJ; Waldo E; Rigel DS; Kopf AW
    Dermatol Clin; 1991 Oct; 9(4):689-93. PubMed ID: 1934643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-evaluating silver-stained nucleolar organizer regions (AgNORs) in problematic cutaneous melanocytic lesions: a study with quantitation and pattern analysis.
    Evans AT; Orrell JM; Grant A
    J Pathol; 1991 Sep; 165(1):61-7. PubMed ID: 1955937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silver staining nucleolar organiser region (AgNOR) study in melanocytic skin tumours.
    Naik R; Raghuveer CV; Jacob DL
    J Indian Med Assoc; 1997 Jul; 95(7):420-1. PubMed ID: 9425842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AgNOR area measurements differentiate benign and malignant melanocytic lesions more accurately than simple counting.
    Gonzalez AP; Kumar D; Sánchez RL
    Am J Dermatopathol; 1994 Aug; 16(4):372-6. PubMed ID: 7526724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of nucleolar organizer region staining in the differential diagnosis of borderline melanocytic lesions.
    Fallowfield ME; Cook MG
    Histopathology; 1989 Mar; 14(3):299-304. PubMed ID: 2468598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
    Pich A; Chiusa L; Margaria E
    Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of nucleolar organizer regions (NORS) in malignant melanoma.
    Ronan SG; Farolan MJ; McDonald A; Manaligod JR; Das Gupta TK
    J Cutan Pathol; 1994 Dec; 21(6):494-9. PubMed ID: 7699115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of the AgNOR method for the differential diagnosis of tumors and for the quantification of non-neoplastic epidermal hyperproliferation in dermatohistology].
    Heinisch G; Barth J
    Zentralbl Pathol; 1994 Mar; 140(1):95-101. PubMed ID: 7515680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [AgNOR expression in skin tumors. Studies of melanocytic, epidermal and fibrohistiocytic lesions].
    Heinisch G; Barth J
    Hautarzt; 1995 Mar; 46(3):177-85. PubMed ID: 7759244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Argyrophilic staining of nucleolar organizer region count and morphometry in benign and malignant melanocytic lesions.
    Li LX; Crotty KA; Palmer AA; Kril JJ; Scolyer RA; Thompson JF; McCarthy SW
    Am J Dermatopathol; 2003 Jun; 25(3):190-7. PubMed ID: 12775980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silver-stained nucleolar organizer regions (AgNORs) as a prognostic value in malignant melanoma.
    Barzilai A; Goldberg I; Yulash M; Pavlotsky F; Zuckerman A; Trau H; Azizi E; Kopolovic J
    Am J Dermatopathol; 1998 Oct; 20(5):473-7. PubMed ID: 9790108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleolar organizer region count and subjective AgNOR pattern assessment (SAPA) score in skin tumors.
    Khanna AK; Giri AK; Khanna A; Kumar M
    J Surg Oncol; 2001 Dec; 78(4):273-8. PubMed ID: 11745824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical evaluation of AgNOR counting in benign naevi and malignant melanoma.
    Orrell JM; Evans AT; Grant A
    J Pathol; 1991 Mar; 163(3):239-44. PubMed ID: 1707452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Argyrophilic nucleolar organizer region counts in malignant melanoma associated with benign intradermal nevus.
    Pich A; Aloi F; Margaria E; Tomasini C
    Dermatologica; 1991; 183(4):246-50. PubMed ID: 1809585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AgNORs in benign, dysplastic, and malignant melanocytic skin lesions.
    Howat AJ; Wright AL; Cotton DW; Reeve S
    Am J Dermatopathol; 1990 Apr; 12(2):156-61. PubMed ID: 2331050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleolar organizer regions in melanocytic dysplasia and melanoma.
    Fallowfield ME; Dodson AR; Cook MG
    Histopathology; 1988 Jul; 13(1):95-9. PubMed ID: 3209193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleolar organizer regions in malignant melanoma and melanocytic nevi. Comparison of two counting methods.
    Di Gregorio C; Losi L; Annessi G; Botticelli A
    Am J Dermatopathol; 1991 Aug; 13(4):329-33. PubMed ID: 1928617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleolar organizer regions in Spitz nevi and malignant melanomas.
    Howat AJ; Giri DD; Cotton DW; Slater DN
    Cancer; 1989 Feb; 63(3):474-8. PubMed ID: 2912525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.